__timestamp | Protagonist Therapeutics, Inc. | Zoetis Inc. |
---|---|---|
Wednesday, January 1, 2014 | 1860000 | 1643000000 |
Thursday, January 1, 2015 | 2963000 | 1532000000 |
Friday, January 1, 2016 | 6961000 | 1364000000 |
Sunday, January 1, 2017 | 11779000 | 1334000000 |
Monday, January 1, 2018 | 13697000 | 1484000000 |
Tuesday, January 1, 2019 | 15749000 | 1638000000 |
Wednesday, January 1, 2020 | 18638000 | 1726000000 |
Friday, January 1, 2021 | 27196000 | 2001000000 |
Saturday, January 1, 2022 | 31739000 | 2009000000 |
Sunday, January 1, 2023 | 33491000 | 2151000000 |
Monday, January 1, 2024 | 2318000000 |
Cracking the code
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Zoetis Inc. and Protagonist Therapeutics, Inc. from 2014 to 2023.
Zoetis Inc., a leader in animal health, has consistently invested in its SG&A expenses, reflecting a strategic focus on growth and market expansion. Over the past decade, their expenses have increased by approximately 31%, reaching a peak in 2023. This steady climb underscores Zoetis's commitment to maintaining its market position.
In contrast, Protagonist Therapeutics, Inc., a smaller biotech firm, has seen a dramatic rise in SG&A expenses, surging by over 1,700% since 2014. This rapid growth highlights their aggressive investment in research and development, aiming to carve out a niche in the competitive biotech sector.
Cost Management Insights: SG&A Expenses for Zoetis Inc. and Intra-Cellular Therapies, Inc.
Breaking Down SG&A Expenses: Zoetis Inc. vs Biogen Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Catalent, Inc. Trends and Insights
Breaking Down SG&A Expenses: Zoetis Inc. vs TG Therapeutics, Inc.
Breaking Down SG&A Expenses: Zoetis Inc. vs CRISPR Therapeutics AG
SG&A Efficiency Analysis: Comparing Zoetis Inc. and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? GSK plc or Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing argenx SE and Protagonist Therapeutics, Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.